Objective: Vascular ultrasound (VUS) is a first-line test for giant cell arteritis (GCA) in Europe but has been of limited use in the United States. We report clinical experience with a multidisciplinary model of VUS for the evaluation of GCA at a large US medical center.
Methods: Patients who underwent VUS for evaluation of GCA between 2013 and 2017 were reviewed.